We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Nov 2023
  • Code : CMI6204
  • Pages :160
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

The global pain patch market size was valued at US$ 5.29 billion in 2023 and is expected to reach US$ 7.45 billion by 2030, grow at a compound annual growth rate (CAGR) of 5% from 2023 to 2030

The pain patch market has gained significant traction as an innovative solution for managing various types of pain effectively. Pain patches, also known as transdermal patches, are designed to deliver controlled doses of pain-relieving medications directly through the skin, providing localized relief for conditions such as chronic pain, post-operative discomfort, and musculoskeletal injuries. These patches offer several advantages, including consistent drug delivery over an extended period, reduced gastrointestinal side effects often associated with oral pain medications, and convenience for patients who may have difficulty swallowing or adhering to a medication regimen. As healthcare trends shift towards personalized care and non-invasive treatment options, the pain patch market is expected to continue its growth trajectory, catering to individuals seeking targeted pain relief with minimal systemic side effects.

The pain patch market is characterized by a diverse range of products that encompass both prescription-based patches containing opioids or non-opioid analgesics, and over-the-counter options with ingredients like lidocaine or capsaicin. Market players are focusing on innovations in patch design, such as incorporating advanced drug delivery technologies and optimizing adhesive properties to ensure comfort and ease of use for patients.

Pain Patch Market Regional Insights

  • North America: North America is the largest market for pain patch, accounting for a share of over 39% in 2022. North America holds a significant share in the pain patch market due to its well-established healthcare infrastructure, high prevalence of chronic pain conditions, and advanced pharmaceutical industry. The region has seen increasing adoption of pain patches as an alternative to traditional pain medications, especially in response to the opioid epidemic. Regulatory efforts to address opioid misuse have led to a push for non-opioid pain relief options like transdermal patches. In addition, the growing aging population and rising awareness of pain management have contributed to the demand for pain patches as a convenient and targeted solution.
  • Europe: Europe is the second-largest market for pain patch, accounting for a share of over 29.0% in 2022. The pain patch market in Europe is driven by factors such as the prevalence of chronic pain conditions, increased focus on patient-centric pain management, and a strong emphasis on minimizing opioid-related risks. Many European countries have robust healthcare systems that support the integration of innovative pain management solutions. Regulatory agencies in the region often prioritize patient safety and effective pain relief, fostering an environment conducive to the adoption of pain patches. Moreover, the rising trend of self-care and home-based treatments has contributed to the popularity of over-the-counter pain patches.
  • Asia-Pacific: Asia Pacific is the fastest-growing market for pain patch, accounting for a share of over 23.5% in 2022. The Asia-Pacific region showcases a mix of opportunities and challenges in the pain patch market. Increasing awareness of pain management, growing healthcare infrastructure, and rising prevalence of chronic conditions contribute to the market's growth. Countries like Japan, South Korea, and China have aging populations that are more susceptible to chronic pain, which drives demand for pain relief solutions. However, factors such as varying regulatory landscapes, cultural perceptions of pain, and access to healthcare can influence the adoption of pain patches across different countries within the region.

Figure 1. Global Pain Patch Market Share (%), by Region, 2023


To learn more about this report, request a free sample copy

Pain Patch Market Drivers:

  • Effective Pain Relief: Pain patches offer localized and controlled delivery of medications directly to the affected area, providing effective relief for various types of pain, including chronic pain, post-operative pain, and musculoskeletal discomfort. The ability to target the source of pain directly contributes to enhanced pain management outcomes and patient satisfaction.
  • Non-Invasive Treatment: Pain patches provide a non-invasive alternative to oral medications and injections. This is particularly appealing to patients who may have difficulty swallowing pills or who prefer to avoid injections. Non-invasive treatment options align with patient preferences and improve treatment adherence.
  • Reduced Systemic Side Effects: Compared to oral pain medications, pain patches often result in fewer gastrointestinal and systemic side effects. By delivering medication directly to the site of pain, patches can minimize the risk of systemic absorption and associated adverse effects, such as nausea or gastrointestinal irritation.
  • Convenience and Long-Lasting Relief: Pain patches offer the advantage of convenience and prolonged relief. Patients can apply a patch and experience continuous pain relief over an extended period, reducing the need for frequent dosing and allowing them to focus on their daily activities.

Pain Patch Market Report Coverage

Report Coverage Details
Base Year: 2022 Market Size in 2023: US$ 5.29 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5% 2030 Value Projection: US$ 7.45 Bn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa 
Segments covered:
  • By Type: Opioid Pain Patches and Non-Opioid Pain Patches
  • By Application: Chronic Pain Patches and Acute Pain Patches
  • By Technology: Traditional Drug Delivery Patches and Advanced Drug Delivery Patches
  • By Formulation: Single Medication Patches and Combination Therapy Patches
  • By Prescription: Prescription Pain Patches and Over-the-Counter (OTC) Pain Patches
  • By Patient Age: Adult Pain Patches and Pediatric Pain Patches
  • By Adhesive Properties: Hypoallergenic Patches and Standard Adhesive Patches
  • By Duration of Action: Short-Acting Patches and Extended-Release Patches
  • By Drug Class: NSAID Patches, Local Anesthetic Patches and Other Medication Patches
  • By Distribution Channel: Retail Pharmacies, Hospitals and Clinics
Companies covered:

Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Pfizer Inc., Novartis AG, Mylan N.V., Endo Pharmaceuticals, Teikoku Pharma USA, Inc., Acorda Therapeutics, Ibsa Institut Biochimique SA, Alembic Pharmaceuticals, Noven Pharmaceuticals, Inc., Teva Pharmaceuticals, Strativa Pharmaceuticals, Galen Limited, and Napp Pharmaceuticals

Growth Drivers:
  • Effective Pain Relief
  • Non-Invasive Treatment
  • Reduced Systemic Side Effects
  • Convenience and Long-Lasting Relief
Restraints & Challenges:
  • Skin Sensitivity and Irritation
  • Dosing Challenges
  • Limited Drug Compatibility

Pain Patch Market Opportunities:

  • Expansion of Indications: Beyond traditional pain relief, there is an opportunity to develop pain patches for a wider range of indications, including neuropathic pain, migraine, and inflammatory conditions like arthritis. Customized patches with specific formulations can cater to diverse patient needs and expand the market's reach.
  • Personalized Pain Management: Advances in pharmacogenomics and personalized medicine enable tailoring pain patch formulations to individual patients based on their genetic makeup and response to medications. Customized patches can optimize pain relief and reduce the risk of adverse effects.
  • Collaboration with Pharma Companies: Collaborations between pain patch manufacturers and pharmaceutical companies can lead to the development of innovative combination therapies. For instance, combining a pain-relieving medication with an anti-inflammatory agent in a single patch could address multiple aspects of pain management.
  • Pediatric Pain Relief: There's a growing need for safe and effective pain management solutions for pediatric patients. Developing child-friendly pain patches with appropriate dosing and formulations can fulfill this unmet need.

Pain Patch Market Trends:

  • Technological Advancements in Drug Delivery: The pain patch market is witnessing continuous innovation in drug delivery technologies. Advanced patches incorporate microelectronics, microneedles, and nanotechnology to enhance drug absorption, optimize dosing, and provide more precise pain relief. These innovations ensure consistent drug release and improve patient comfort.
  • Focus on Non-Opioid Solutions: As the opioid epidemic prompts heightened concerns about opioid use, the pain patch market is aligning with the trend towards non-opioid alternatives. Pain patches offer a viable option for patients seeking effective pain relief without the risk of opioid-related dependence or side effects.
  • Integration of Wearable Technologies: Smart pain patches that integrate with wearable devices and mobile apps are gaining traction. These patches can provide real-time feedback on medication adherence, track pain levels, and offer personalized pain management insights, enhancing patient engagement and outcomes.
  • Combination Therapies: Pain patches are evolving to offer combination therapies that target multiple pain pathways simultaneously. Manufacturers are exploring the integration of pain-relieving medications with anti-inflammatory agents, muscle relaxants, or complementary treatments in a single patch.

Pain Patch Market Restraints:

  • Skin Sensitivity and Irritation: Skin reactions, including irritation and allergies, can occur due to the adhesive materials or drug components in pain patches. These adverse effects may lead to discomfort and reduced patient compliance, impacting the overall effectiveness of the treatment.
  • Dosing Challenges: Designing pain patches with the right dosage to provide effective pain relief without causing adverse effects can be challenging. Ensuring consistent drug delivery and accurate dosing over the patch's lifespan is essential but can pose difficulties.
  • Limited Drug Compatibility: Not all medications are suitable for transdermal delivery. Certain drugs have molecular characteristics that hinder effective penetration through the skin, limiting the range of medications that can be administered via pain

Figure 2. Global Pain Patch Market Share (%), by Drug Class, 2023


To learn more about this report, request a free sample copy

Recent Developments

New product launches

  • On October 2023, Nysh.in, a pharmaceutical company, announced the launch of cramp care pain relief patch under the BluHeat category, a company business segment. This product provides the comfort and relief available for cramping menstruation. This ground-breaking invention uses heat treatment to provide a safe and all-natural means of pain alleviation.
  • In February 2023, Hisamitsu Pharmaceutical Co., Ltd. a pharmaceutical company, announced the launch of a Salonpas Pain Relieving FLEX Patch Lidocaine 4% featuring thin, flexible, and highly adhesive patch technology.
  • In February 2022, NexGel, Inc. a healthcare company, announced the launch of its MEDAGEL Bug Bite Relief Patch. These cooling patches, made in the U.S. using NEXGEL's soothing hydrogel technology, provide instant relief to irritated skin caused by insect bites.
  • In August 2021, Hisamitsu Pharmaceutical Co., Inc. a pharmaceutical company, announced that it had obtained approval of the additional indications of cancer pain relief for pediatric patients for FENTOS Tapes, transdermal, pain management patch in Japan.
  • In October 2020, Vizuri Health Sciences Consumer Healthcare Inc., a pharmaceutical company, announced the launch of patch to relieve pain “PainBloc24 Flexi-Stretch Pain Tape”. PainBloc24 Flexi-Stretch Pain Tape combines a potent anesthetic that helps numb pain with an inventive 4-way stretch patch that is modeled after the lightweight, flexible fabric used in kinesiology tape.

Acquisition and partnerships

  • In January 2021, Endo International plc. a pharmaceutical company, announced that its has entered into definitive agreements with Radius Health, Inc. a biotechnology company, to register, commercialize and distribute abaloparatide thermal patch on an exclusive basis in Canada.

Top companies in Pain Patch Market

  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • Mylan N.V.
  • Endo Pharmaceuticals
  • Teikoku Pharma USA, Inc.
  • Acorda Therapeutics
  • Ibsa Institut Biochimique SA
  • Alembic Pharmaceuticals
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceuticals
  • Strativa Pharmaceuticals
  • Galen Limited
  • Napp Pharmaceuticals

*Definition: A pain patch, also known as a transdermal patch, is a medical product designed to deliver controlled doses of pain-relieving medications directly through the skin. These patches provide localized relief for various types of pain, including chronic pain, post-operative discomfort, and musculoskeletal injuries.

Frequently Asked Questions

Skin sensitivity, dosing challenges, limited drug compatibility, and regulatory hurdles are the key factors hampering the growth of the pain patch market

Effective pain relief, non-invasive treatment, reduced systemic side effects, and patient convenience are major factors driving growth of the market

Opioid Pain Patches segment is the leading segment in the market

Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Pfizer Inc., Novartis AG, Mylan N.V., Endo Pharmaceuticals, Teikoku Pharma USA, Inc., Acorda Therapeutics, Ibsa Institut Biochimique SA, Alembic Pharmaceuticals, Noven Pharmaceuticals, Inc., Teva Pharmaceuticals, Strativa Pharmaceuticals, Galen Limited, and Napp Pharmaceuticals.

North America is expected to lead the market

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount

Reliability and Reputation

DUNS Registered
DMCA Protected


Reliability and Reputation


Reliability and Reputation


Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo